Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins.
Sign Up to like & getrecommendations! Published in 2022 at "Nano letters"
DOI: 10.1021/acs.nanolett.2c03881
Abstract: Anthrax infections caused by Bacillus anthracis are an ongoing bioterrorism and livestock threat worldwide. Current approaches for management, including extended passive antibody transfusion, antibiotics, and prophylactic vaccination, are often cumbersome and associated with low patient… read more here.
Keywords: single low; anthrax toxins; nanovaccine long; anthrax ... See more keywords